1 Weber KT, BrullarCG.Pa thological hyper trophy and cardial inter stitium:fibrosis and renis-angio-tensin-aldo sterone sy stem.J Circulation, 1991;8 3: 1849
2 Devereux RB, Reichek N.Echocardiographic determi-nation of le ft ventricularmass in man:ana tomic validation of the method.J Circulation,1977;55:613
3 Carroll EP, Janicki JS, Pick K, et al.My ocardial stiffness and reparatine fibrosis following coronary embolisation in therats.J Cardio vasc Res, 1989;23: 655
4 Chapman D, Weber KT, M ahboubeh E.Re gu-lation offibrillarcollagentypes I and Ⅲ and base-men t menbranetype Ⅳ collagen g ene expression in pressureoverloaded rat my ocardium.Cir Res, 1990; 67:787
5 Eghbali M,Weber K T.Colla gen and the my ocardi-um:fibrillarstructure, bio synthesis and degradation in relation to hypertrophy andits reg ression.Mol Cell Biochem, 1990;9 6:1
6 Die z J, Panizo A,M arin GJ, et al.Serum markers of collagentype I met abolismis spoutaneosully hyper-tension rats relation to my ocardial fibrosis.J Circu-lation, 1996;9 3:1025
7 Weber KT, Brilla CG.My ocardial fibrosis and therenin-angio ter sion-a ldosterone sy stem.J Cardiovasc Pharmacol, 1992;20(Supple):4 8
8 Varg a J,Dia z-Perez A, Ro senbloom J.PGE causes a coordina te de crease in the steady state levels offi-bronectin andtype s I and Ⅲ procollagen mRNAs in norma l human dermal fibrobla sts.Biochem Biophys Res Commun, 1987:147
9 Zhou G, Ty agi Sc,Weber KJ.Bradykinin regula tes collagen turnover in cardiacfibroblasts.Clin Res, 1993;41:6 30
10 Brilla CG, Janicki JS, Weber KT.Impaired diastolic function and coronary reserve in genetic hyper ten-sion:role ofinterstitial fibrosis and medialt hickening ofintramy ocardial coronary arterie s.Circ Res, 1991; 69:107
11 Ror ce llati C, Verdecohia P, Schivlaci G, et al. Long-term effects of benazepril on ambulatory blood pressure, left ventriccularmass diastolic filling and aortic flowin essential hyper tension.J Clin Pharmacol Thera Toxicol, 1991;29:187

[1]	CHEN Xi, LI Yongjun. Effects of Chinese patent medicine for activating blood circulation on cardiac repair after myocardial infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 680-688.
[2]	XU Jianfei, LIN Li. Research progress in pharmacological and non-pharmacological treatments of hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 433-441.
[3]	YUAN Zhen, CHEN Bilian. Review of bleeding events in clinical studies of clopidogrel [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(3): 341-349.
[4]	XING Kai, GONG Jinyu, LUO Jianquan. Advances on pharmacogenomics of diuretics-related adverse reactions [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 204-212.
[5]	DANG Xiangji, ZHOU Lin, WANG Yixuan, ZENG Lu. Individualized antithrombotic therapy on one patient with chronic renal insufficiency [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 477-480.
[6]	PU Chun, TAO Qingsong, ZHU Xiang, QIN Mingming, WU Qiwen, FENG Gang. Value of three cardiac markers in the early diagnosis of acute myocardial infarction [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(1): 82-86.
[7]	JIANG Peng-li, WU Jing, SUN He. Association of cognitive decline, diabetes mellitus and cancer with statins use: gaining insight through the FDA pharmacovigilance database [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(10): 1132-1138.
[8]	WANG Pan, XIE Shan-shan, GUO Jian-jun, BU Hai-zhi, CHEN Xi-jing. Research overview in absorption, distribution, metabolism and excretion of dihydropyridine calcium antagonists [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 937-943.
[9]	WANG Zhen-shan, LI Ling, DENG Xiao-lan, LI Hui, YU Min, YAN Jin, CHEN Ben-mei, YANG Guo-ping, OU-YANG Dong-sheng. LC-MS determination of terazosin in human plasma and application [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(5): 530-534.
[10]	ZHANG Hong-xia, WU Yong-jie, GAO Ming-tang. Protective effects of DDPH on myocardial ischemia reperfusion injury in isolated rat hearts [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(2): 160-165.
[11]	WANG Zhan-qing, WANG Jin-ping, XU Jing-feng. Isosorbide dinitrate induces late preconditioning against myocardial infarction in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(12): 1385-1388.
[12]	ZHU Shen-yin, ZHOU Yuan-da, DU Guan-hua. Research progress of xanthine oxidoreductase in biological functions and its inhibitor development [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1081-1086.
[13]	XUE Hao, GAO Min, LIU Guo-shu, WANG Hai. Effect of iptakalim hydrochloride on extracellular matrix of kidney in spontaneously hypertensive rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1122-1128.
[14]	WANG Zhan-qing, YING Xiang-yu, XU Jing-feng. Advances in preclinical studies on combination therapy of myocardial ischemia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 847-850.
[15]	YU Shuang, YU Li-mei, YUAN Mu, YU Hong, WU Qin, SHI Jin-shan. Effect of naftopidil'ramification-BWYJ on benign prostatic hyperplasia in mice and rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(8): 873-877.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments